“The logistic complications certainly were not helpful, but I think that the low uptake is more than that. The low uptake reflects that most of the public is no longer concerned about Covid,” said Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center in Boston.
Barouch said HV.1 could be slighter better than EG.5 at spreading among people or infecting those with prior immunity to Covid — but not enough to cause alarm among scientists. “I would expect that it might be a slight increase in transmissibility or immune escape, which is why it appears to be dominating. Does it change any booster recommendations so far? Probably not,” he said. Read Full Article
https://cvvr.hms.harvard.edu/wp-content/uploads/2023/09/NBC.jpg 1080 1080 Sesedzayi Persesuh https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.png Sesedzayi Persesuh2023-10-30 10:34:172023-10-30 10:34:17A new Covid variant has become dominant amid slow uptake of the updated shots